OTC Adverse Event Draft Guidance Addresses Multi-Product Reporting
This article was originally published in The Tan Sheet
Executive Summary
Over-the-counter drug companies need only submit one safety report when a serious adverse event involves multiple drugs, according to FDA's draft guidance on adverse event reporting and recordkeeping for nonprescription drugs